IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
38 hedge funds and large institutions have $2.19M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
6
Reduced
3
Closed
2
Calls
$2.29M
Puts
–
Net Calls
+$2.29M
Net Calls Change
+$76K
Top Buyers
Top Sellers
1 |
SCM
1
Shaolin Capital Management
Miami,
Florida
|
$12K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$4K |
3 |
3
Capstone Investment Advisors
New York
|
$0 |